Dysiherbaine: A new neurotoxic amino acid from the Micronesian marine sponge Dysidea herbacea

Journal of the American Chemical Society

Volumn 119, Issue 18, 1997, Pages 4112-4116

  Sakai, Ryuichi ^a   Kamiya, Hisao ^a   Murata, Michio ^b   Shimamoto, Keiko ^c  

^a KITASATO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; DIAMINO ACID; DICARBOXYLIC ACID; DOMOIC ACID; GLUTAMATE RECEPTOR; GLUTAMIC ACID; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROTOXIN;

ARTICLE; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR OVERHAUSER EFFECT; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN STRUCTURE; SPONGE (PORIFERA); SYNAPTIC MEMBRANE;

EID: 0031004214     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja963953z     Document Type: Article

References (36)

1. (a) Narahashi, T.; Moore, J. W.; Scott, W. R. J. Gen. Physiol. 1964, 47, 965-974.
2. (b) Gray, W.; R., Olivera, B. M.; Cruz, L. J. Annu. Rev. Biohem. 1988, 57, 665-700.
3. (c) Trainer, V., L.; Baden, D. G.; Catterall, W. A. J. Biol. Chem. 1994, 269, 19904-19909.
4. (d) Sattelle, D. B.; Harrow, I. D.; David, J. A., Pelhate, M.; Callec, J. J.; Gepner, J. I.; Hall, L. M. J. Exp. Biol. 1985, 118, 37-52.
5. (a) Shinozaki, H.; Konishi, S. Brain Res. 1970, 24, 368-371.
6. (b) Debonnel, G.; Beauchesne, L.; de Montigny, C. Can. J. Physiol. Pharmacol. 1989, 67, 29-33.
7. (c) Roberts, P. J.; Davies, S. W. Biochem. Soc. Trans. 1987, 218-219.
8. Wright, J. L. C.; Boyd, R. K.; De Freitas, A. S. W.; Falk, M.; Foxall, R. A.; Jamison, W. D.; Laycock, M. V.; McCulloch, A. W.; McInnes, A. G.; Odense, P.; Pathak, V. P.; Quilliam, M. A.; Ragan, M. A.; Sim, P. G.; Thibault, P.; Walter, J. A. Can. J. Chem. 1989, 67, 481-490.
9. (a) Tasker, R. A. R.; Connell, B. J.; Strain, S. M. Can. J. Physiol. Pharmacol. 1991, 69, 378-382.
10. (b) Tryphonas, L.; Truelove, J.; Nera, E.; Iverson, F. Toxicol Pathol. 1990, 18, 1-9.
11. (a) Watkins, J. C. In Kainic Acid as a Tools in Neurobiology; McGeer, E. G., Olney, J. W., Mcgeer, P. L., Eds.; Raven Press: New York, 1978; pp 37-69.
12. (b) Watkins, J. C.; Olverman, H. J. Trends Neurosci. 1987, 10, 265-272.
13. Krogsgaard-Larsen, P.; Hansen, J. J. Toxicol. Lett. 1992, 64/65, 409-416.
14. Note that a shift of 0.05 ppm was observed on C3, a methylene carbon. See: Jeremic, D.; Milosavljevic, M. Lj. Tetrahedron 1982, 38, 3325-3328.
15. CH of 10 and 5 Hz were performed.
16. Treatment of 1 with diazomethane gave a complicated mixture. Acetylations of 1 with pyridine-acetic anhydride or acetic acid-acetic anhydride were both unsuccessful.
17. 1H NMR spectrum in the δ 3.85 region. H2 and H3b was also separated into two sets. This may be due to partial racemization at C2 during the reaction.
18. C,H were successfully demonstrated by the following: (a) Matsumori, N.; Murata, M.; Tachibana, K. Tetrahedron 1995, 51, 12229-12238. (b) Matsumori, N.; Nonomura, T.; Sasaki, M.; Tachibana, K.; Satake, M.; Yasumoto, T. Tetrahedron Lett. 1996, 37, 1269-1272.
19. C,H were successfully demonstrated by the following: (a) Matsumori, N.; Murata, M.; Tachibana, K. Tetrahedron 1995, 51, 12229-12238. (b) Matsumori, N.; Nonomura, T.; Sasaki, M.; Tachibana, K.; Satake, M.; Yasumoto, T. Tetrahedron Lett. 1996, 37, 1269-1272.
20. (a) Lemieux, R. U.; Nagabhushan, T. L.; Paul, B. Can. J. Chem. 1972, 50, 773.
21. (b) Schwarcz, J. A.; Perlin, A. S. Can. J. Chem. 1972, 50, 3667-3676.
22. (c) Wasylishen, R.; Schaefer, T. Can. J. Chem. 1973, 51, 961-973.
23. (a) Otting, G.; Wüthrich, K. Q. Rev. Biophys. 1990, 23, 39-96.
24. (b) Kurz, M.; Schmieder, P.; Kessler, H. Angew. Chem., Int. Ed. Engl. 1991, 30, 1329-1331.
25. (c) Wollborn, U.; Leibfritz, D. J. Magn. Reson. 1992, 98, 142-146.
26. C,H can be calculated from the relative intensity of a crosspeak in the PS-HMBC spectrum and that in the reference spectrum; see ref 11a and the following: (a) Zhu, G.; Bax, A. J. Magn. Reson. 1993, 104A, 353-357. (b) Zhu, G.; Live, D.; Bax, A. J. Am. Chem. Soc. 1994, 116, 8370-8371.
27. C,H can be calculated from the relative intensity of a crosspeak in the PS-HMBC spectrum and that in the reference spectrum; see ref 11a and the following: (a) Zhu, G.; Bax, A. J. Magn. Reson. 1993, 104A, 353-357. (b) Zhu, G.; Live, D.; Bax, A. J. Am. Chem. Soc. 1994, 116, 8370-8371.
28. C,H values should have an intermediate value.
29. 2J(H3-C2) as a reference value.
30. Uemura, D.; Takahashi, K.; Yamamoto, T.; Katayama, C.; Tanaka, J.; Okumura, Y.; Hirata, Y. J. Am. Chem. Soc. 1985, 107, 4796-4798.
31. 3H]AMPA was inhibited by AMPA (5.6 ± 1.1) or Glu (124 ± 41).
32. Davis, D. G. J. Am. Chem. Soc. 1989, 111, 5466-5468.
33. Witten, J. L.; Schaffer, M. H.; O'Shea, M.; Cook, J. C.; Hemling, M. E.; Rinehart, K. L., Jr. Biochem. Biophys. Res. Commun. 1984, 124, 350-358.
34. (a) London, E. D.; Coyle, J. T. Mol. Pharmacol. 1979, 15, 492.
35. (b) Murphy, D. E.; Snowhill, E. W.; Williams, M. Neurochem. Res. 1987, 12, 775.
36. (c) Murphy, D. E.; Hutchison, A. J.; Hurt, S. D.; Williams, M.; Sills, M. A. Br. J. Pharmacol. 1988, 95, 932.